300289 Beijing Leadman Biochemistry
- 4.10
- +0.18+4.59%
Beijing Leadman Biochemistry News
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement on the Progress of Using Idle Funds for Cash Management
Beijing Leadman Biochemistry: Announcement regarding the signing of a supplementary agreement for the house rental contract by the company.
Beijing Leadman Biochemistry: Progress announcement on the use of idle own funds for delegated financial management
Beijing Leadman Biochemistry: 2023 Annual Equity Distribution Implementation Notice
Beijing Leadman Biochemistry: Legal Opinion of the 2023 Annual General Meeting of Shareholders
Beijing Leadman Biochemistry: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Beijing Leadman Biochemistry: 2024 First Quarter Report
Beijing Leadman Biochemistry: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors
Beijing Leadman Biochemistry: Notice on applying for a comprehensive bank credit line
Beijing Leadman Biochemistry: Notice on changes in accounting policies
Beijing Leadman Biochemistry: 2024 First Quarter Report Disclosure Prompt Announcement
Beijing Leadman Biochemistry: Announcement of Resolutions of the 16th Meeting of the Fifth Board of Directors
Leadman: Investor Relations Activity Record Form for April 9, 2024
Leadman: Progress Announcement on the Use of Idle Raised Funds for Cash Management
Leadman: Announcement on holding the 2023 online results briefing
Leadman: Progress announcement on the use of idle own funds for delegated financial management
Leadman: Progress Announcement on the Use of Idle Raised Funds for Cash Management
Leadman: Progress announcement on the use of idle own funds for delegated financial management
Leadman: Corrections to the 2023 Accrued Asset Impairment Preparation
Analysis
Price Target
No Data
